The Set-Point Study: Evaluating Effects of Changing Glucose Target on Bionic Pancreas Performance
Clinical trial NCT02509065 · COMPLETED
Trial details
- NCT number
- NCT02509065
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2017-12-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.